Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by M. Roberto
Impact of predators and resource abundance levels on physiological traits of Fissurella crassa (Archeogastropoda)
Ayuda Buscar en la ayuda Buscar en la ayuda Impact of predators and resource abundance levels on physiological traits of Fissurella crassa (Archeogastropoda) Autores: M. Roberto García Huidobro, José Miguel Pulgar Águila, Víctor Manuel Pulgar Águila, Marcela Aldana Localización: Hidrobiológica, ISSN 0188-8897, Vol. 25, Nº. 2, 2015, págs.
The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System.
Alcohol Research : Current Reviews, Feb 2023 This is a preview of a remote PDF: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843413/pdf/ S. Wolfe, V. Vozella, M. Roberto. , Alcohol Research : Current Reviews, pp. 03, Volume 42, Issue 1, DOI: 10.35946/arcr.v42.1.03
Upper thermal limits and risk of mortality of coastal Antarctic ectotherms
Mauricio J. Carter1*†, M. Roberto García-Huidobro2†, Marcela Aldana2†, Enrico L. Rezende3†, Francisco Bozinovic3†, Cristóbal Galbán-Malagón4† and José M.
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification
Publication History Published online: December 07, 2019Accepted: November 28, 2019; Received: November 16, 2019;
5-fluorouracil degradation rate as a predictive toxicity biomarker in early stage gastrointestinal cancer
Background: Prediction and early management of severe toxicity might avoid both therapy's interruption and the benefit loss of adjuvant chemotherapy. However, predictive toxicity biomarkers are not yet available.
P-0395-Fluorouracil Degradation Rate in Patients with Recurrent Gastrointestinal Cancer Treated with Metronomic Capecitabine
Introduction: 5-Fluoruracil (5-FU) is the milestone chemotherapeutic drug for the treatment of the gastrointestinal tract (GI) tumours. Dihydropyrimidine dehydrogenase (DPD) is the key enzyme involved in 5-FU catabolism. DPD deficiency may often subtend the development of severe toxicities in patients treated with a fluoropyrimidine-based chemotherapy. The degradation rate of 5-FU is a phenotypic marker of the 5-FU metabolism.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with M.
Contact M., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack